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Purpose: To investigate the genetic basis for autosomal recessive severe early-onset retinitis pigmentosa (RP) in a
consanguineous Israeli Muslim Arab family.
Methods: Haplotype analysis for all known genes underlying autosomal recessive RP was performed. Mutation screening
of the underlying gene was done by direct sequencing. An in vitro splicing assay was used to evaluate the effect of the
identified mutation on splicing.
Results: Haplotype analysis indicated linkage to the Tubby-like protein 1 (TULP)1 gene. Direct sequencing revealed a
homozygous single base insertion, c.1495+2_1495+3insT, located in the conserved donor splice-site of intron 14. This
mutation co-segregated with the disease, and was not detected in 114 unrelated Israeli Muslim Arab controls. We used an
in vitro splicing assay to demonstrate that this mutation leads to incorrect splicing.
Conclusions: To date, 22 distinct pathogenic mutations of TULP1 have been reported in patients with early-onset RP or
Leber congenital amaurosis. Here we report a novel splice-site mutation of TULP1, c.1495+2_1495+3insT, underlying
autosomal recessive early-onset RP in a consanguineous Israeli Muslim Arab family. This report expands the spectrum
of pathogenic mutations of the TULP1 gene.
Inherited  retinal  degenerations  are  a  clinically  and
genetically heterogeneous group of diseases. Many of them
cause visual loss due to premature death of rod and cone
photoreceptors. Leber congenital amaurosis (LCA) is the most
severe form of hereditary retinal degeneration and the most
common genetic cause of congenital visual impairment in
infants and young children. In these children both rods and
cones have degenerated or are nonfunctional at birth, or are
lost within the first years of life, and thus electroretinographic
(ERG) responses are extinguished or severely reduced [1-3].
Retinitis pigmentosa (RP) is a relatively less severe form of
retinal degeneration. In most forms of RP, rod degeneration
exceeds cone degeneration; thus the first clinical symptom is
usually night blindness, followed by gradual restriction of the
visual field. As the disease progresses, both rods and cones
degenerate.  Additional  ophthalmologic  findings  include
characteristic  pigmentation  of  the  midperipheral  retina,
attenuation of the retinal arterioles, and pale appearance of the
optic  disc  [4].  The  diagnostic  boundary  separating  severe
early-onset RP from LCA is not distinct, and in some cases
both diagnoses may apply [4,5].
Both  LCA  and  RP  are  genetically  heterogeneous
disorders. In most patients, the disease is limited to the eye
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(nonsyndromic RP/LCA), with no extraocular manifestations.
Nonsyndromic RP can be inherited as autosomal recessive,
autosomal dominant, or X-linked. Mitochondrial and digenic
patterns of inheritance have also been described [5]. Over 45
genes and loci have been implicated in nonsyndromic RP, of
which at least 29 are associated with an autosomal recessive
mode of inheritance. LCA is most frequently inherited as
autosomal  recessive,  although  autosomal  dominant  forms
have also been described [1]. Fifteen genes and loci have been
implicated  in  nonsyndromic  LCA  (Retnet;  Retinal
Information Network).
One of the genes underlying both autosomal recessive RP
and LCA is TULP1, encoding tubby-like protein 1. TULP1 is
a member of the tubby-like family of proteins, including TUB
and  TULP1–3.  These  proteins  are  defined  by  the  highly
conserved “tubby domain” located in their COOH-terminal
part. TULP proteins are found in multicellular organisms, and
all  four  family  members  are  conserved  among  vertebrate
genomes.  TULPs  are  localized  primarily  to  the  nervous
system, and all of them are expressed in the retina. Although
the exact function of TULP proteins is not well understood,
these proteins appear to play an important role in neuronal
development  and  function  [6].  Two  of  the  TULP  family
members have been linked to retinal degeneration. A naturally
occurring  null  mutation  in  the  tubby  gene  causes
photoreceptor  and  cochlear  degeneration  and  adult-onset
obesity  in  mice  [7,8].  Mutations  of  TULP1  cause  retinal
degeneration in both humans and mice [9-12]. Recent studies
Molecular Vision 2008; 14:675-682 <http://www.molvis.org/molvis/v14/a81>
Received 12 August 2007 | Accepted 05 March 2008 | Published 21 April 2008
© 2008 Molecular Vision
675indicate that TULP1 is involved in the vesicular trafficking of
photoreceptor  proteins,  both  in  the  nerve  terminal  during
synaptic transmission, and at the inner segment during protein
translocation to the outer segment [13-15].
To date, 22 distinct pathogenic mutations of TULP1 have
been  reported  in  patients  with  LCA  or  RP  (Table  1)  [2,
16-21].  Here  we  report  a  novel  splice-site  mutation  of
TULP1,  c.1495+2_1495+3insT,  underlying  severe  early-
onset RP in a consanguineous Israeli Muslim Arab family.
METHODS
Patients: Nine members (six males and three females) of a
Muslim Arab consanguineous family from Northern Israel
(family TB13) were ascertained for this study. They included
three affected individuals (31, 38, and 41 years old), and six
unaffected individuals (39, 40, 42, 45, 68, and 70 years old).
The study was performed in accordance with the Declaration
of Helsinki and written informed consent was obtained from
all  participants.  The  research  was  approved  by  the  local
institutional review board at Bnai Zion Medical Center and by
the National Helsinki Committee for Genetic Research in
Humans. Digital fundus photographs were taken with a Zeiss
450  Plus  fundus  camera  (Carl  Zeiss,  Inc.,  Oberkochen,
Germany), combined with an OIS WinStation 3200 digital
system  (Ophthalmic  Imaging  Systems,  Inc.,  Sacramento,
CA). DNA control samples were obtained from 114 Muslim
Arab  individuals  from  Northern  Israel  (both  males  and
females, 20–40 years old) who presented for routine genetic
testing and consented for the use of their DNA samples in
additional genetic studies.
Haplotype  analysis:  Genomic  DNA  was  extracted  from
venous blood samples according to a standard protocol [22].
DNA  samples  were  PCR  amplified  with  fluorescent  dye-
labeled primers flanking microsatellite repeat markers linked
to all known autosomal recessive RP and LCA genes and loci
(Retnet;  Retinal  Information  Network).  The  microsatellite
repeat  markers  used  to  test  for  linkage  to  TULP1  were
D6S1583, D6S1611, and D6S291, which span an interval of
2.5 Mb flanking the gene. PCR products were separated by
electrophoresis on an ABI 310 Genetic Analyzer (PE Applied
Biosystems, Foster City, CA), and genotypes were determined
by  Genescan  and  Genotyper  software,  using  a
Genescan-400HD-ROX  size  standard  (PE  Applied
Biosystems).
Mutation  analysis:  Specific  primers  were  used  to  PCR
amplify  the  15  exons  of  TULP1,  including  intron-exon
boundaries [2]. PCR products were purified with the Wizard
SV PCR clean-up system (Promega Corporation, Madison,
WI). Mutation screening was performed by direct sequencing
with the Big Dye terminator cycle sequencing kit on an ABI
3130xl Genetic Analyzer (PE Applied Biosystems). To screen
control  DNA  samples  for  the  c.1495+2_1495+3insT
mutation,  we  created  a  mismatch-primer  restriction-based
assay. Briefly, DNA samples were subjected to amplification
in a 25 μl reaction volume with the following primers: F-CTT
CTC CGG TCA GTC CTG AG and R- GTG GAG AAG AGC
CAG ACC TGG GCC CTC AGG GAC TC. The reverse
primer includes one mismatched base (underlined), which, in
combination with the mutant allele, but not with the wild-type
(WT) allele, creates a DrdI restriction site (GAC NNN NNN
GTC). Twenty μl of the PCR product were digested with 3 U
DrdI  and  1X  of  the  recommended  buffer  (New  England
Biolabs, Beverly, MA) for several hours at 37 °C. The entire
digestion volume (30 μl) was visualized by electrophoresis on
a  5%  NuSieve  3:1  agarose  gel  (Cambrex  Bio  Science,
Rockland, ME) in 1XTBE buffer. Expected band sizes were
286 bp for the WT allele and 251 and 35 bp for the mutant
allele.
Splice-site  score  predictions:  The  genomic  sequence
environment of the mutation was analyzed for 5′ and 3′ splice-
Figure  1.  Pedigree  and  haplotype
analysis.  Shown  is  a  pedigree  of  a
consanguineous  Israeli  Muslim  Arab
family  segregating  early-onset
autosomal  recessive  retinitis
pigmentosa (family TB13). Haplotype
analysis  performed  on  this  family
demonstrated  co-segregation  of  a
haplotype of three polymorphic marker
alleles,  linked  to  TULP1  on
chromosome 6p21.31, with autosomal
recessive  retinitis  pigmentosa  in  this
family. The mutation-bearing haplotype
is  marked  by  a  box.  Males  are
represented  by  squares,  females  are
represented  by  circles.  Affected
individuals  are  marked  by  black
shadings.
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676sites using Splice Site Prediction by Neural Network, Splice
Site Finder, and MaxEntScan.
In vitro splicing assay: To create wt and mutant minigene
constructs,  we  PCR-amplified  DNA  fragments  harboring
TULP1 exons 12, 13, 14, and 15, each flanked by 79–183 bp
of intronic sequences, from genomic DNA derived from a
patient homozygote for the c.1495+2_1495+3insT mutation
or from a normal control. The c.1495+1G>A mutation was
generated  by  site-directed  mutagenesis,  using  the
QuikChange Site-Directed Mutagenesis Kit (Stratagene, La
Jolla, CA). The four fragments were inserted in tandem into
the pCMV-Script mammalian expression vector (Stratagene).
Y79 retinoblastoma cells were obtained from the American
Type Culture Collection and cultured in RPMI 1640 medium
containing  L-glutamine  and  sodium  bicarbonate  (Sigma-
Aldrich,  St  Louis,  MO),  and  supplemented  with  10  mM
HEPES, 1 mM sodium pyruvate, and 20% fetal bovine serum
(FBS; Biologic Industries, Beit Haemek, Israel). Cells were
maintained at 37 °C and 5% CO2. Constructs were transfected
into  Y79  cells  by  electroporation.  20×106  cells  were
electroporated with 15 μg of DNA at room temperature in
0.3 ml of RPMI 1640 containing 20% FBS, using an ECM
830  square  wave  electroporator  (BTX,  a  subdivision  of
Genetronics, San Diego, CA) at a setting of 300 V, 10 ms and
in LV mode. Twenty-four hours following transfection, total
RNA was extracted from cells with TRI reagent (Sigma), and
treated  with  RQ1  RNase-free  DNase  (Promega).  Reverse
transcription was performed with 1 μg of total RNA in a
20  μl  reaction  volume  using  200  U  of  M-MLV  Reverse
Transcriptase and 100 ng of random primers (Stratagene).
Two μl of cDNA were subjected to PCR amplification with
the T3 vector-derived forward primer (GCG CGA AAT TAA
CCC TCA CTA AAG) and a TULP1-specific reverse primer
(ACC GGT AGT CTA GGG TGA AG). Cycling conditions
were 95 °C for 5 min, followed by 35 cycles of 95 °C for 30
s, 55 °C for 30 s, and 72 °C for 30 s, and a final step of 72 °C
for 10 min.
RESULTS
Clinical  findings:  The  family  included  five  affected
individuals, four of whom live in Israel. In total, nine family
members participated in the study (three affected and six
unaffected; Figure 1). All affected family members, who are
currently over 30 years old, had severe retinal dystrophy since
early childhood. Symptoms included low visual acuity, night
blindness, and congenital nystagmus. The most detailed early
clinical records were available for individual IV-18. He was
born  with  congenital  cataract  on  his  left  eye,  which  was
surgically removed at the age of one year, with no secondary
implantation of an intraocular lens. At the age of eight years
he had reduced visual acuity (right eye: 6/30; left eye: 20 cm
finger  counting).  Funduscopic  examination  at  the  time
revealed vascular attenuation. Both scotopic and photopic
ERGs were extinct. Visual evoked potentials (VEP) from both
eyes  were  reduced,  although  typical  waves  with  normal
latency could be detected. At the age of 23 years, his visual
TABLE 1. CURRENTLY KNOWN MUTATIONS OF THE TULP1 GENE
Exon/Intron Base change Amino acid
substitution
Phenotype Notes Reference
Intron 2 c.99+1G>A Aberrant splicing LCA/Early onset RP Found in compound heterozygosity with p.E402X and
with p.I459K
[2,11]
Intron 4 c.350-2delAGA, (IVS4-2delAGA) Aberrant splicing Early onset RP [21]
Exon 5 c.394del24 p.E120-D127del RP Found in heterozygosity; second mutant allele not
identified
[18]
Intron 7 c.718+2T>C Aberrant splicing Juvenile RP [16]
Exon 10 c.937delC p.Q301fsX8 Early onset RP [21]
Intron 10 c.999+5G>C Aberrant splicing Juvenile RP [16]
Exon 11 c.1102G>T p.G368W LCA [2]
Exon 11 c.1145T>C p.F382S Early onset RP [19]
Exon 12 c.1198C>T p.R400W LCA [2]
Exon 12 c.1204G>T p.E402X LCA Found in compound heterozygosity with c.99+1G>A [2]
Intron 12 c.1224+4A>G, (IVS12+4A>G) Aberrant splicing RP Found in heterozygosity; second mutant allele not
identified
[18]
Exon 13 c.1259G>C p.R420P Early onset RP Found in compound heterozygosity with p.F491L [11]
Exon 14 c.1376 T>A p.I459K Early onset RP Found in compound heterozygosity with c.99+1G>A [11]
Exon 14 c.1381C>G p.L461V Juvenile RP [16]
Exon 14 c.1472 T>C p.F491L Early onset RP Found in compound heterozygosity with p.R420P [11]
Exon 14 c.1444C>T p.R482W Early onset RP Found in compound heterozygosity with p.L504fsX140 [17]
Exon 14 c.1502G>A p.K489R RP [18]
Exon 14 c.1522 G>A p.A496T RP Found in heterozygosity; second mutant allele not
identified
[18]
Intron 14 c.1495+1G>A, (IVS14+1G>A) Aberrant splicing Early onset RP [9,24]
Intron 14 c.1495+2_1495+3insT Aberrant splicing Early onset RP Current report
Intron 14 c.1496-6C>A, (IVS14-6C>A) Aberrant splicing RP [18]
Exon 15 c.1511-1521del, TGCAGTTCGGC p.L504fsX140 Early onset RP Found in compound heterozygosity with p.R482W [17]
Exon 15 c.1593-1594 dup, TTCGCC p.FA531-532dup LCA/Early onset RP [20]
Abbreviations: RP represents retinitis pigmentosa, LCA represents Leber congenital amaurosis.
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677acuity deteriorated (right eye: 1/60; left eye: light perception).
Funduscopic findings at this age included retinal vascular
attenuation  and  bone  spicule-type  pigmentation.  No
consistent VEP responses were obtained. The reduced VEP
responses, in addition to the extinct ERG responses, indicate
impairment of both peripheral and macular function. This
conclusion is supported by funduscopic findings at the age of
31  years,  demonstrating  both  peripheral  and  macular
abnormalities. These include vascular attenuation, peripheral
bone spicule-type pigment deposits, accompanied by salt and
pepper-like changes, and signs of maculopathy (Figure 2).
Current visual acuity is 30 cm finger counting (right eye), and
no light perception (left eye).
Haplotype analysis: Family TB13 is consanguineous, and
retinal  degeneration  segregates  in  an  autosomal  recessive
mode. Since signs of retinal dysfunction presented at birth or
in very early childhood, we performed haplotype analysis with
markers linked to all known genes and loci linked to both
autosomal  recessive  RP  and  LCA  (Retnet;  Retinal
Information  Network).  A  haplotype  of  three  polymorphic
marker  alleles  (D6S1583,  D6S1611,  D6S291)  linked  to
TULP1 on chromosome 6p21.31, co-segregated with retinal
degeneration in this family (Figure 1).
Mutation  analysis:  To  detect  the  pathogenic  mutation  in
TULP1, we determined the sequence of each of the 15 exons,
including  exon-intron  boundaries,  in  one  of  the  affected
individuals from family TB13 (Figure 1, individual IV-11).
We identified a homozygous T nucleotide insertion between
positions +2 and +3 of intron 14, within the conserved donor
splice-site (c.1495+2_1495+3insT; see Figure 3A). Analysis
of all available family members revealed that the mutation co-
segregates with retinal degeneration in this family. Affected
individuals are homozygotes for the mutation, while their
parents  are  heterozygotes.  Unaffected  siblings  are  either
heterozygotes  or  homozygotes  for  the  WT  allele.
Heterozygote carriers of the mutation were asymptomatic.
To  screen  control  DNA  samples  for  c.
1495+2_1495+3insT,  we  created  a  mismatch-primer
restriction–based  assay  (Figure  3B).  We  found  c.
1495+2_1495+3insT was not detected in 228 chromosomes
derived from unrelated Israeli Muslim Arab control subjects
from  Northern  Israel,  indicating  that  it  is  not  a  common
polymorphism in this population.
In vitro splicing assay: According to splice-site consensus
sequence in mammals, a purine is located at position +3 of the
donor site [23]. Indeed, in the wt TULP1 allele a G is located
at position +3 of intron 14 (UCSC Genome Bioinformatics
and Figure 3A). However, in the mutant allele the nucleotide
at position +3 is a pyrimidine (T; Figure 3A). To predict the
Figure  2.  Fundus  photographs  of
individual  IV-18  (right  eye).  The
photographs show vascular attenuation,
peripheral  bone  spicule  pigmentation,
accompanied  by  salt  and  pepper-like
changes,  and  signs  of  maculopathy,
including edema and a yellow perifoveal
ring.
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678Figure  3.  The  c.1495+2_1495+3insT
mutation.  A:  Shown  are  nucleotide
sequence  traces  of  the  boundary
between TULP1 exon and intron14 in a
non-carrier  individual  (wt),  an
individual  heterozygote  for  the  c.
1495+2_1495+3insT  mutation  (het),
and an affected individual homozygote
for the mutant allele (mut). The exon-
intron  boundary  is  marked.  B:  A
mismatch-primer  restriction–based
assay  used  to  screen  control  DNA
samples for the c.1495+2_1495+3insT
mutation.  The  reverse  PCR  primer
included one mismatched base, which,
in combination with the mutant allele,
but not with the WT allele, created a
DrdI  restriction  site.  A  286  bp  PCR
product derived from the WT allele was
not  digested  by  DrdI,  while  in  the
presence  of  the  MUT  two  restriction
fragments  of  251  and  35  bp  were
obtained. Digestion of a PCR product
derived  from  a  heterozygote  for  the
mutation (HET) yielded three fragments
(286,  251,  and  35  bp).  The  35  bp
fragment is not visible.
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679effect of this insertion on splicing, we performed in silico
analysis of the sequence using three different web-based tools
(Splice  Site  Prediction  by  Neural  Network,  Splice  Site
Finder, and MaxEntScan). All three algorithms predicted that
the c.1495+2_1495+3insT mutation would lead to elimination
of intron 14 donor site.
Due to the limited expression pattern of TULP1 (mainly
restricted to the retina [10]), we could not evaluate the effect
of c.1495+2_1495+3insT on splicing in patient-derived RNA.
Alternatively, we used an in vitro splicing assay approach. For
this  purpose,  we  created  a  set  of  minigene  constructs
harboring TULP1 exons 12 to 15, flanked by 79–183 bp of
intronic  sequences,  downstream  of  a  CMV  promoter.  In
addition to a WT construct, we generated constructs harboring
two mutant alleles, both affecting the donor splice-site of
intron 14: the c.1495+2_1495+3insT mutation identified in
family  TB13;  and  the  c.1495+1G>A  (IVS14+1G>A)
mutation, which was previously identified in two Dominican
kindreds [9] (Figure 4A). Constructs harboring either the WT
or  the  mutant  alleles  were  transfected  into  the  Y79
retinoblastoma cell line, followed by RNA extraction and RT–
PCR  analysis.  To  analyze  the  results,  we  sequenced  the
splicing products derived from each construct. RNA derived
from  the  WT  construct  was  correctly  spliced  (a  430  bp
product),  while  RNA  derived  from  the  mutant  constructs
yielded two types of aberrantly spliced products. In these two
splicing products, an alternative acceptor splice-site, located
20 bp upstream of the original site within exon 15, was used.
In one product (218 bp) exon 14 was skipped, while in another
product (430 bp) a cryptic donor splice-site, located 20 bp
downstream of the mutant splice-site within intron 14, was
used (Figure 4).
The length of WT TULP1 protein is 542 amino acids.
Skipping  of  exon  14  was  expected  to  lead  to  premature
translation  termination,  after  the  insertion  of  37  incorrect
amino acids, starting at position 442 of the protein. The use
of a cryptic intron 14 donor splice-site (in combination with
the alternative intron 15 acceptor splice-site) was expected to
yield a protein with normal length (542 amino acids), however
six amino acids (at positions 489–494 of the protein) were
replaced.
DISCUSSION
The aim of the current study was to investigate the genetic
basis  for  autosomal  recessive  severe  early-onset  RP  in  a
consanguineous Israeli Muslim Arab family. Genetic analysis
revealed  a  novel  splice-site  mutation  of  TULP1,  c.
1495+2_1495+3insT.  We  performed  an  in  vitro  splicing
assay, which demonstrated that intron 14 donor splice-site
harboring  the  c.1495+2_1495+3insT  mutation  is  not
efficiently  recognized  by  the  human  splicing  machinery.
Although  the  exact  effect  of  this  splicing  mutation  on
TULP1 transcripts in vivo is not known, the expected outcome
is incorrect splicing, leading to an abnormal protein product.
Interestingly,  two  of  the  seven  splice-site  mutations  of
TULP1  which  have  been  reported  to  date,  c.1495+1G>A
(IVS14+1G>A) and c.1496–6C>A (IVS14–6C>A), affect the
donor and acceptor sites of intron 14 [9] (Figure 4 and Table
Figure  4.  Minigene  constructs  and
products obtained in the in vitro splicing
assay.  A:  Shown  is  a  schematic
representation of the constructs, which
include  TULP1  exons  12  to  15
(represented by boxes), flanked by 79–
183  bp  of  intronic  sequences
(represented  by  straight  lines).
Constructs harbored either the wild-type
(WT) or one of two mutant alleles at the
donor  splice-site  of  intron  14:  c.
1495+2_1495+3insT  and  c.
1495+1G>A.  Also  shown  are  the
locations of primers used for RT–PCR
analysis (indicated by arrows) and the
obtained  splicing  products.  Sizes  of
exonic  and  intronic  fragments  are
indicated  below  them.  B:  WT  and
mutant constructs were transfected into
Y79 cells, followed by RNA extraction
and  RT–PCR  analysis.  No  PCR
products  were  obtained  from  cells
transfected  with  the  empty  pCMV-
script vector. β-actin (ACTB), a 437 bp
product, served as an internal control for
RNA quality and quantity.
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6801). This finding further demonstrates the importance of correct
splicing of intron 14 for generation of normally functioning
TULP1 protein.
The  phenotype  associated  with  TULP1  mutations  is
usually described as LCA or early-onset RP (Table 1). In a
recent paper, den Hollander et al. were able to predict the
involvement of TULP1 based on the disease phenotype, which
they believed is specific for TULP1. This phenotype included
early-onset nyctalopia with nystagmus; relative preservation
of the isopters on kinetic perimetry, despite poor visual acuity;
and a perifoveal yellow annular ring [16]. Clinical findings in
affected individuals from family TB13, including early-onset
of symptoms, nystagmus, myopia, central vision impairment,
and pigmentary retinopathy, are consistent with this report
(Figure  2).  Interestingly,  intrafamilial  variability  between
affected individuals harboring the same TULP1 mutation has
been  recently  reported  [20].  This  report  indicates  that
additional genetic as well as environmental factors contribute
to the phenotypic outcome elicited by TULP1 mutations.
In summary, TULP1 is one of several genes known to
cause early-onset autosomal recessive retinal degeneration.
Some of these genes are major contributors to this phenotype.
For  example,  over  85  pathogenic  mutations  have  been
reported for CRB1, over 55 for GUCY2D, and over 50 for
RPE65 (The Human Gene Mutation Database). In contrast,
since  the  identification  of  the  first  TULP1  pathogenic
mutations  in  1998  [9,11],  only  22  distinct  mutations  of
TULP1 have been reported worldwide (Table 1). In a recent
study, TULP1 mutations were identified in approximately 4%
of patients with LCA and juvenile RP [16]. This relatively
small number suggests that TULP1 mutations are a rare cause
for  early-onset  retinal  degeneration.  Here  we  report  a
consanguineous  Israeli  Muslim  Arab  family  segregating
severe early-onset retinal degeneration due to a novel splice-
site mutation of TULP1. This report expands the spectrum of
pathogenic mutations of TULP1.
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